A novel STAT3 inhibitor, HJC0152, exerts potent antitumor activity in glioblastoma

Aberrant expression and activation of signal transducer and activator of transcription 3 (STAT3) is implicated in several malignancies, including glioblastoma, and is correlated with poor outcomes in patients with glioblastoma, rendering STAT3 a potential therapeutic target. However, few STAT3 inhib...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am J Cancer Res
Main Authors: Li, Zhaoqing, Zhu, Tingting, Xu, Yini, Wu, Chuanqiang, Chen, Jinliang, Ren, Yu, Kong, Lingping, Sun, Shanshan, Guo, Wenyu, Wang, Yu, Jing, Chao, Dong, Jiabin, Zhou, Jia, Zhang, Lun, Shen, Qiang, Zhou, Xuan
Formato: Artigo
Idioma:Inglês
Publicado em: e-Century Publishing Corporation 2019
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6511646/
https://ncbi.nlm.nih.gov/pubmed/31105997
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados